Raymond W Cohen has bought stock on 3 days since Aug 2019

Raymond W. Cohen is a veteran medical technology executive with over 40 years of experience in the life sciences industry, currently serving as an independent director on the board of Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), where he has recently engaged in insider trading activities( He joined Kestra's board in 2024, bringing expertise in external defibrillation and commercial growth strategies to support the company's ASSURE Wearable Cardioverter Defibrillator( Cohen holds board positions at multiple medtech firms, including InspireMD, Spectrum Vascular, Nalu Medical (as Chairman), Tulavi (as Vice Chairman), and others(

Cohen co-founded Axonics, Inc. in 2013, served as CEO, took it public in 2018, and led it to a $3.7 billion acquisition by Boston Scientific in 2024, earning recognitions such as Deloitte Technology Fast 500 top ranking and Financial Times' fastest-growing company in the Americas( Previously, he was CEO of Vessix Vascular (acquired by Boston Scientific in 2012) and Cardiac Science Inc. (acquired by Zoll Medical), and Chairman of SoniVie Ltd. (acquired by Boston Scientific for $600 million in 2025)( Awards include the 2024 MedTech MVP Award, Orange County Business Journal Businessperson of the Year, SoCalBio Lifetime Achievement Award (2021), and Ernst & Young Entrepreneur of the Year (2020)( He holds a B.S. in Business Management from Binghamton University(

Written by Perplexity from public sources.